Lien Van Den Bossche
Gent, VLG 9052, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
MH002, a Novel Butyrate-Producing Consortium of Six Commensal Bacterial Strains Has Immune-Modulatory and Mucosal-Healing Properties.
Journal: International journal of molecular sciences
Published: April 04, 2025
A novel LPS-responsive beige-like anchor protein (LRBA) mutation presents with normal cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and overactive TH17 immunity.
Journal: The Journal of allergy and clinical immunology
Published: December 22, 2017
Structural Activation of Pro-inflammatory Human Cytokine IL-23 by Cognate IL-23 Receptor Enables Recruitment of the Shared Receptor IL-12Rβ1.
Journal: Immunity
Published: June 30, 2017
T84 monolayers are superior to Caco-2 as a model system of colonocytes.
Journal: Histochemistry and cell biology
Published: January 09, 2017
Tauroursodeoxycholic acid protects bile acid homeostasis under inflammatory conditions and dampens Crohn's disease-like ileitis.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: October 12, 2016
Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
Journal: Applied and environmental microbiology
Published: October 10, 2016
Treatment of Intestinal Fibrosis in Experimental Inflammatory Bowel Disease by the Pleiotropic Actions of a Local Rho Kinase Inhibitor.
Journal: Gastroenterology
Published: September 09, 2016
Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis.
Journal: The Journal of pathology
Published: August 20, 2016
Reduced Mucosa-associated Butyricicoccus Activity in Patients with Ulcerative Colitis Correlates with Aberrant Claudin-1 Expression.
Journal: Journal of Crohn's & colitis
Published: May 08, 2015
Tauroursodeoxycholic acid inhibits experimental colitis by preventing early intestinal epithelial cell death.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: February 28, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026